Loading clinical trials...
Loading clinical trials...
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Live SK08 Powder (Bacteroides Fragilis) in Adult Patients with Active Mild to Moderate Ulcerative Colitis
Conditions
Interventions
Live SK08 powder
Placebo
Start Date
July 1, 2025
Primary Completion Date
July 1, 2027
Completion Date
August 1, 2027
Last Updated
December 16, 2024
NCT07271069
NCT07245394
NCT07333716
NCT06896305
NCT07269223
NCT07224113
Lead Sponsor
Guangzhou Zhiyi Biotechnology Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions